AUTHOR=Muraleedharan Anjaly , Pillai Avani , Nair Bipin G. , Krishnarajabhatt Hemavathi Shivapura , Ramachandran Chithra , Aji Anjana , Vanuopadath Muralidharan 

TITLE=An exploratory single arm study to evaluate the role of an Ayurvedic treatment protocol as a prerequisite for in vitro fertilization in women with diminished ovarian reserve incorporating multi-omics approaches: study protocol

JOURNAL=Frontiers in Medicine

VOLUME=Volume 12 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1666888

DOI=10.3389/fmed.2025.1666888

ISSN=2296-858X

ABSTRACT=IntroductionOvarian reserve depicts the quality and quantity of oocytes remaining in the ovaries and gives an idea about ovarian function at a given time. Because of aging, ovarian reserve diminish physiologically. However, many women face a non-physiologic reduction of ovarian reserve, irrespective of age. To date, standard-of-care treatment options are not available to treat diminished ovarian reserve (DOR). Studies shows that DOR patients mostly undergo in vitro fertilization (IVF) with donor cycles. Hence, identifying effective treatment modalities for DOR is an area of great clinical relevance. This trial will investigate the role of an Ayurvedic treatment protocol in DOR patients prior to IVF. Reports suggest that the factors influencing oocyte maturation can be determined through multi-omics analysis of the follicular fluid. However, the impact of Ayurvedic interventions in improving therapeutic outcomes has yet to be explored in detail. Hence this study also aims to explore whether therapeutic targets can be identified through multi-omics analysis of the follicular fluid collected from the participants after Ayurvedic treatment.Materials and methodsAn open label single arm trial will be conducted to explore the role of an Ayurveda treatment protocol as a prerequisite for IVF in women with DOR. Forty women diagnosed with DOR satisfying eligibility criteria will be recruited to the study. Out of them, thirty participants will be undergoing Ayurveda treatment prior to their next IVF, and ten participants will be assigned to control group for follicular fluid analysis. Within subject change in serum anti-mullerian hormone and antral follicle count will be the primary outcomes evaluated. The multiomics analysis of follicular fluid will be done in 20 participants recruited to the study (treatment group 10 and control group 10).DiscussionThis multidisciplinary exploratory clinical trial will be the first study to explore the role of an Ayurvedic treatment protocol in managing DOR. The multi-omics approaches will be helpful in identifying potential biomarkers associated with treatment response. The information gained through the study might be useful in planning a safe and feasible pre-conception care for DOR patients undergoing IVF.Clinical trial registrationctri.nic.in, identifier CTRI/2023/11/059872.